6. Inventory

Components of inventory, net of reserves as of June 30, 2019 and December 31, 2018 are as follows:


	June 30,		December 31,
	2019		2018
Raw Materials	$	3,361,556	$	3,621,548
Work in Process		244,743		256,129
Finished Goods		1,811,338		1,798,101
Total	$	5,417,637	$	5,675,778

As of June 30, 20192019, we classified $1.4 million and $1.6 million, respectively, of inventory as non-current, all of which was related to Triferic or the active pharmaceutical ingredient for Triferic. As of June 30, 20192019 we had total Triferic inventory aggregating $3.5 million and $8.0 million respectively, against which we had reserved $1.7 million and $5.8 million respectively.

The $1.8 million net value of Triferic inventory consisted of $0.4 million of Dialysate Triferic finished goods with expiration dates ranging from March 2020 to May 2021, and $1.4 million of Triferic API with estimated useful lives extending through 2023. In addition, see subsequent events note 17 for potential risk relating to the inventory valuation.